Segment Wealth Management LLC grew its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 28.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,388 shares of the pharmaceutical company’s stock after acquiring an additional 750 shares during the quarter. […]